XML 62 R18.htm IDEA: XBRL DOCUMENT v3.23.1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]  
Schedule of Restatement of Previously Issued Financial Statements
Balance Sheets:
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of June 30, 2022:
 
 
  
As of June 30, 2022
 
 
  
As Previously
Reported
 
  
Restatement
Adjustment
 
  
As Restated
 
Total Assets
  
$
276,393,463
 
  
$
  
 
  
$
276,393,463
 
  
 
 
 
  
 
 
 
  
 
 
 
Total current liabilities
  
 
412,495
 
  
 
  
 
  
 
412,495
 
Deferred underwriting commissions
  
 
9,625,000
 
  
 
(3,609,375
  
 
6,015,625
 
  
 
 
 
  
 
 
 
  
 
 
 
Total liabilities
  
 
10,037,495
 
  
 
(3,609,375
  
 
6,428,120
 
  
 
 
 
  
 
 
 
  
 
 
 
Class A ordinary shares subject to possible redemption
  
 
275,043,954
 
  
 
  
 
  
 
275,043,954
 
Preferred shares
  
 
  
 
  
 
  
 
  
 
  
 
Class A ordinary shares
  
 
91
 
  
 
  
 
  
 
91
 
Class B ordinary shares
  
 
688
 
  
 
  
 
  
 
688
 
Additional
paid-in
capital
  
 
  
 
  
 
  
 
  
 
  
 
Accumulated deficit
  
 
(8,688,765
  
 
3,609,375
 
  
 
(5,079,390
  
 
 
 
  
 
 
 
  
 
 
 
Total shareholders’ deficit
  
 
(8,687,986
  
 
3,609,375
 
  
 
(5,078,611
  
 
 
 
  
 
 
 
  
 
 
 
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
  
$
276,393,463
 
  
$
  
 
  
$
276,393,463
 
  
 
 
 
  
 
 
 
  
 
 
 
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of September 30, 2022:
 
 
  
As of September 30, 2022
 
 
  
As Previously
Reported
 
  
Restatement
Adjustment
 
  
As Restated
 
Total Assets
  
$
276,978,583
 
  
$
  
 
  
$
276,978,583
 
  
 
 
 
  
 
 
 
  
 
 
 
Total current liabilities
  
 
467,636
 
  
 
  
 
  
 
467,636
 
Deferred underwriting commissions
  
 
9,625,000
 
  
 
(3,609,375
  
 
6,015,625
 
  
 
 
 
  
 
 
 
  
 
 
 
Total liabilities
  
 
10,092,636
 
  
 
(3,609,375
  
 
6,483,261
 
  
 
 
 
  
 
 
 
  
 
 
 
Class A ordinary shares subject to possible redemption
  
 
275,905,944
 
  
 
  
 
  
 
275,905,944
 
Preferred shares
  
 
  
 
  
 
  
 
  
 
  
 
Class A ordinary shares
  
 
91
 
  
 
  
 
  
 
91
 
Class B ordinary shares
  
 
688
 
  
 
  
 
  
 
688
 
Additional
paid-in
capital
  
 
  
 
  
 
  
 
  
 
  
 
Accumulated deficit
  
 
(9,020,776
  
 
3,609,375
 
  
 
(5,411,401
  
 
 
 
  
 
 
 
  
 
 
 
Total shareholders’ deficit
  
 
(9,019,997
  
 
3,609,375
 
  
 
(5,410,622
  
 
 
 
  
 
 
 
  
 
 
 
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
  
$
276,978,583
 
  
$
  
 
  
$
276,978,583
 
  
 
 
 
  
 
 
 
  
 
 
 
 
 
Statement of Changes in Stockholders’ Deficit:
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported accumulated deficit in the statement of changes in stockholders’ deficit for the six months ended June 30, 2022:
 
 
  
For the Six Months Ended June 30, 2022
 
 
  
As Previously
Reported
 
  
Restatement
Adjustment
 
  
As Restated
 
Balance—December 31, 2021
   $ (8,053,173    $ —        $ (8,053,173
Adjustment for accretion of Class A ordinary shares subject to possible
redemption amount
     (43,954      3,609,375        3,565,421  
Net loss
     (591,638      —          (591,638
    
 
 
    
 
 
    
 
 
 
Balance—June 30, 2022
   $ (8,688,765    $ 3,609,375      $ (5,079,390
    
 
 
    
 
 
    
 
 
 
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported accumulated deficit in the statement of changes in stockholders’ deficit for the nine months ended September 30, 2022:
 
 
  
For the Nine Months Ended September 30, 2022
 
 
  
As Previously
Reported
 
  
Restatement
Adjustment
 
  
As Restated
 
Balance—December 31, 2021
   $ (8,053,173    $ —        $ (8,053,173
Adjustment for accretion of Class A ordinary shares subject to possible redemption amount
     (905,944      3,609,375        2,703,431  
Net loss
     (61,659      —          (61,659
    
 
 
    
 
 
    
 
 
 
Balance—September 30, 2022
   $ (9,020,776    $ 3,609,375      $ (5,411,401
    
 
 
    
 
 
    
 
 
 
Statement of Cash Flows:
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2022:
 
 
  
For the Six Months Ended June 30, 2022
 
 
  
As Previously
Reported
 
  
Restatement
Adjustment
 
  
As Restated
 
Supplemental disclosure of noncash financing activities:
  
  
  
Extinguishment of deferred underwriting commissions allocated to Public Shares
  
$
  
 
  
$
3,609,375
 
  
$
3,609,375
 
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously
reported statement of cash flows for the nine months ended September 30, 2022:
 
 
  
For the Nine Months Ended September 30,
2022
 
 
  
As Previously
Reported
 
  
Restatement
Adjustment
 
  
As Restated
 
Supplemental disclosure of noncash financing activities:
  
  
  
Extinguishment of deferred underwriting commissions allocated to Public
Shares
  
$
  
 
  
$
3,609,375
 
  
$
3,609,375